Some Appreciation for Management
I have been a grumpy grader of management's investor engagement efforts but think we should also take a moment to show some appreciation for what they have pulled off in NASH. Basically, they created a phase III ready trial out of next to nothing. They have never performed a phase I or II NASH trial and yet they conjured up an asset for shareholders by sheer will power and gutsy calls. Time will tell what that asset will be worth, but it is remarkable that we are even talking about it at this point. If there is anything good that came out of the failure to get Trogarzo launched successfully, it was the necessity to come up with something else to give TH a future, without spending much money, that led to NASH (and cancer). Past and present board members and management team members deserve credit for pulling this off. The market may not like the delay in the trial's start but the fact there is even a trial to start, backed by both main regulatory bodies, is quite an achievement that we should all appreciate. But we still do need better investor engagement so more than just the small number of us on this site can appreciate what has been pulled off.